Geode Capital Management’s ACELYRIN SLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,773,818
Closed -$4.38M 4513
2025
Q1
$4.38M Buy
1,773,818
+64,732
+4% +$154K ﹤0.01% 2720
2024
Q4
$5.37M Buy
1,709,086
+57,472
+3% +$278K ﹤0.01% 2715
2024
Q3
$8.14M Buy
1,651,614
+388,631
+31% +$2.01M ﹤0.01% 2492
2024
Q2
$5.57M Buy
1,262,983
+32,988
+3% +$155K ﹤0.01% 2667
2024
Q1
$8.3M Buy
1,229,995
+455,864
+59% +$3.46M ﹤0.01% 2435
2023
Q4
$5.78M Buy
774,131
+65,351
+9% +$558K ﹤0.01% 2630
2023
Q3
$7.21M Buy
708,780
+361,012
+104% +$7.67M ﹤0.01% 2451
2023
Q2
$7.27M Buy
+347,768
New +$7.11M ﹤0.01% 2493

Other funds holding SLRN

Geode Capital Management's SLRN Position: Q2 2025 in Review

Geode Capital Management sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 1,773,818 shares — an estimated $4.38M sold.

Geode Capital Management first reported a position in SLRN in Q2 2023 and held it in 8 quarters. The position peaked at $8.3M in Q1 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • Geode Capital Management reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • Geode Capital Management sold 1,773,818 ACELYRIN shares in Q2 2025, an estimated $4.38M.
  • Geode Capital Management first reported a position in ACELYRIN in Q2 2023 and held it in 8 quarters.
  • Geode Capital Management's ACELYRIN position peaked at $8.3M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Geode Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.